Rhinomed Ltd (ASX: RNO) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Rhinomed Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $48.17 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 285.72 million
Earnings per share -0.025
Dividend per share N/A
Year To Date Return -44.79%
Earnings Yield N/A
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Rhinomed Ltd (ASX: RNO)
Latest News

a young girl smiles as she is about to get a nasal swab test from a medical practitioner while her masked parent looks on in the background.
Healthcare Shares

Rhinomed (ASX:RNO) share price surges 9% on world-first trial result

The company is developing a new respiratory diagnostic test for children.

Read more »

stock market gaining
Share Gainers

Why Centaurus Metals, IGO, Novonix, Rhinomed shares are storming higher

These ASX shares are storming higher on Friday...

Read more »

Businessman outside jumps in the air
Share Market News

Why the Rhinomed (ASX:RNO) share price is soaring 20% today

The company's shares hit a multi-year high in morning trade...

Read more »

child holds swab and testing cup
Share Market News

Why the Rhinomed (ASX:RNO) share price is rocketing 23% today

The medical device company is ending the week on a positive note

Read more »

green arrow representing a rise in the share price
Share Gainers

Why Core Lithium, IRESS, Lake Resources, & Rhinomed are storming higher

Here's why these ASX shares are storming higher...

Read more »

Sonic Healthcare share price represented by man receiveing nasal swab from medical professional
Share Gainers

Why the Rhinomed (ASX:RNO) share price is rocketing 90% higher today

This medical device company is benefiting from COVID testing...

Read more »

share price rocket
Share Gainers

Rhinomed (ASX:RNO) share price tries following Starpharma’s path to COVID glory

The Rhinomed Ltd (ASX: RNO) share price surged to a six-month high as it takes a leaf out of the…

Read more »

RNO ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Rhinomed Ltd

Formerly Consegna Group Limited (CGP), 15/11/2013.

RNO Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
12 May 2022 $0.17 $0.00 0.00% 66,635 $0.18 $0.19 $0.17
11 May 2022 $0.17 $0.00 0.00% 3,000 $0.17 $0.17 $0.17
10 May 2022 $0.18 $-0.01 -5.56% 10,000 $0.18 $0.18 $0.18
09 May 2022 $0.18 $0.00 0.00% 109,356 $0.19 $0.19 $0.18
06 May 2022 $0.18 $-0.02 -10.26% 289,638 $0.20 $0.20 $0.18
04 May 2022 $0.20 $-0.02 -9.30% 46,567 $0.19 $0.20 $0.19
02 May 2022 $0.22 $0.02 10.26% 100,513 $0.20 $0.22 $0.20
29 Apr 2022 $0.20 $0.01 5.26% 72,174 $0.20 $0.20 $0.20
28 Apr 2022 $0.19 $-0.02 -9.52% 138,619 $0.21 $0.21 $0.19
27 Apr 2022 $0.21 $0.01 4.88% 26,323 $0.20 $0.21 $0.20
26 Apr 2022 $0.21 $0.00 0.00% 48,542 $0.21 $0.21 $0.21
22 Apr 2022 $0.21 $-0.01 -4.65% 52,595 $0.21 $0.21 $0.21
21 Apr 2022 $0.22 $0.01 4.88% 96,800 $0.21 $0.22 $0.21
20 Apr 2022 $0.21 $-0.01 -4.65% 78,014 $0.22 $0.22 $0.21

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
06 May 2022 Eric Knight Issued 7 $1,491
Rights issue.
06 May 2022 Michael Johnson Issued 51 $9,716
Rights issue.
06 May 2022 Michael Johnson Issued 29 $5,699
Rights issue.
19 Apr 2022 Ronald (Ron) Dewhurst Issued 1 $285,866
Rights issue.
19 Apr 2022 Ronald (Ron) Dewhurst Issued 303 $57,751
Rights issue.
19 Apr 2022 John McBain Issued 4 $924,961
Rights issue.
13 Apr 2022 Ronald (Ron) Dewhurst Issued 150 $37,125
On-market trade.
04 Mar 2022 Michael Johnson Buy 54 $10,015
On-market trade. As per announcement on 04/03/2022.
04 Mar 2022 Ronald (Ron) Dewhurst Transfer 3 $615,000
Off-market transfer. Assuming 3,000,000 indirect shares transferred to direct shares.
04 Mar 2022 Ronald (Ron) Dewhurst Buy 100 $22,000
On-market trade.
04 Mar 2022 Ronald (Ron) Dewhurst Transfer 3 $615,000
Off-market transfer. Assuming 3,000,000 indirect shares transferred to direct shares.
03 Feb 2022 John McBain Buy 2 $861,000
Off-market trade.
03 Feb 2022 Michael Johnson Transfer 2 $861,000
Off-market transfer. As per announcement on 07-02-2022
21 Dec 2021 Brent Scrimshaw Expiry 1 $430,500
Exercise of options. As per announcement on 22-12-2021
21 Dec 2021 Eric Knight Expiry 1 $430,500
Exercise of options.
20 Dec 2021 Ronald (Ron) Dewhurst Buy 3 $861,000
Exercise of options.
20 Dec 2021 Ronald (Ron) Dewhurst Exercise 3 $861,000
Exercise of options. As per announcement on 20/12/2021.
20 Dec 2021 Michael Johnson Transfer 242 $64,130
Off-market transfer. Assuming 242,002 direct shares transferred to indirect shares
20 Dec 2021 Michael Johnson Exercise 3 $861,000
Exercise of options.
20 Dec 2021 Michael Johnson Buy 3 $861,000
Exercise of options.
20 Dec 2021 Michael Johnson Transfer 242 $64,130
Off-market transfer. Assuming 242,002 direct shares transferred to indirect shares
02 Jul 2021 John McBain Buy 487 $77,107
On-market trade.
24 Jun 2021 John McBain Buy 506 $75,959
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Michael Johnson Chief Executive OfficerManaging Director Feb 2013
Mr Johnson is a director of Cogentum, one of Australia's leading market oriented strategic advisory firms based in Melbourne. Over the past 20 years, Mr Johnson has worked in and for a wide spectrum of companies from ASX 300 through to start-up companies in life sciences, cleantech, financial services, energy and utilities, manufacturing, marketing and communication, automotive, and consumer packaged goods. His most recent work has focused on helping companies implement technology platforms and achieve sustainable growth through business model innovation. Mr Johnson has been a Principal at two leading global consulting firms where he advised on innovation and competing in heavily regulated industries. Before that, he held roles within some of the world's most successful marketing and communication firms where he launched a number of high profile new products and brands.
Mr Ronald (Ron) Richard Dewhurst Non-Executive ChairmanNon-Executive Director Dec 2015
Mr Dewhurst has spent 40 years in the investment banking and asset management industries, covering Australia, Asia, Europe and United States of America. He was formerly Head of Americas for J P Morgan Asset Management and Senior Executive Vice President and Head of Global Investment Managers for Legg Mason Inc. based in the United States, before returning to live in Melbourne in 2014.
Mr Brent Scrimshaw Non-Executive Director Feb 2014
Mr Scrimshaw brings understanding of the requirements of building disruptive brands and businesses worldwide. During a 19-year career with Nike Inc. where he held the position of Vice President and Chief Executive of Western Europe amongst other leadership roles and was a member of the global corporate leadership team where he was responsible for many of Nike's major growth and brand strategies worldwide. He is now the CEO and Executive Director of Enero Group Limited (ASX: EGG) and is also a non-executive director of Kathmandu Holdings Limited (ASX/NZX: KMD).
Dr Eric Knight Non-Executive Director Feb 2014
Dr Knight brings experience in corporate strategy and management, having previously worked for Boston Consulting Group, and subsequently serving as Professor of Strategic Management at University of Sydney and more recently as Professor of Strategic Management and Executive Dean of Macquarie Business School. Dr Knight is a Graduate of the Australian Institute of Company Directors and is known internationally for his work on design-led strategy.
Professor John McBain Non-Executive Director May 2021
Prof McBain is the former Head of Reproductive Services at The Royal Women's Hospital in Melbourne, Australia. He is also the former President of the Fertility Society of Australia, and was a founder of Melbourne IVF, now Virtus Health (ASX:VRT). Prof McBain served as a Director of Melbourne IVF and subsequently as a Director of Virtus Health prior to its listing on the ASX. Assoc.
Mr Sean Slattery Chief Financial OfficerCompany Secretary Mar 2020
-
Sean Slattery Chief Financial OfficerCompany Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Merrill Lynch (Australia) Nominees Pty Limited 103,324,186 40.71%
Fifty Second Celebration Pty Ltd <Mcbain Family A/C> 29,153,143 11.49%
Thirty-Fifth Celebration Pty Ltd <Jc Mcbain Super Fund A/C> 15,626,133 6.16%
Kroy Wen Pty Ltd 7,565,320 2.98%
Kroy Wen Pty Ltd <Dewhurst Super Fund A/C> 7,184,680 2.83%
Citicorp Nominees Pty Limited 5,637,484 2.22%
Hsbc Custody Nominees (Australia) Limited <Gsco Customers A/C> 5,249,141 2.07%
Ubs Nominees Pty Ltd 3,038,868 1.20%
Mutual Trust Pty Ltd 3,000,000 1.18%
Kensington Capital Management Pty Ltd 2,800,000 1.10%
Abingdon Nominees Pty Ltd <Abingdon Noms Invest A/C> 2,200,000 0.87%
Hsbc Custody Nominees (Australia) Limited 2,011,207 0.79%
Argus Nominees Pty Ltd <The Halstead Super Fund A/C> 1,725,285 0.68%
Ken Siebel 1,249,929 0.49%
Jasforce Pty Ltd 1,158,009 0.46%
Netwealth Investments Limited <WRAP Services A/C> 1,128,578 0.44%
Bnp Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 1,072,470 0.42%
Opima Pty Limited <Opima A/C> 1,000,000 0.39%
Mhbiat Pty Ltd <Jason Phillip Walls Disc A/C> 1,000,000 0.39%
Mr Phillip Keith Biggs & Dr Katie Louise Spearritt 1,000,000 0.39%
Mr Calum Mcbain 980,700 0.39%
Dh Newton Nominees Pty Ltd <Dh Newton S/F No 2 A/C> 795,993 0.31%

Profile

since

Note